WPI 2227 (Flutamide 125 mg)
Pill imprint WPI 2227 has been identified as Flutamide 125 mg.
Flutamide is used in the treatment of prostate cancer; hirsutism and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 2227
- Strength:
- 125 mg
- Color:
- Brown & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiandrogens
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals, Inc.
More about flutamide
Consumer resources
- Other brands: Eulexin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
